Table 1.
Clinicopathologic data of the study group.
| Clinical stage n (%) | IA2 | 15 (15) | |
| IB1 | 51 (50) | ||
| IB2 | 8 (8) | ||
| IIA | 7 (7) | ||
| IIB | 21 (20) | ||
| Histologic type n (%) | Squamous | 91 (90) | |
| Non-squamous | 11 (10) | ||
| Histologic grade n (%) | G1 | 19 (19) | |
| G2 | 62 (61) | ||
| G3 | 21 (20) | ||
| Tumor size n (%) | ≤ 4 cm | 69 (68) | |
| > 4 cm | 33 (32) | ||
| Mean number of removed lymph nodes (range) | 13.8 (1-40) | ||
| Lymph node status n (%) | Negative | 77 (76) | |
| Positive | 25 (24) | ||
| Mean number of positive lymph nodes (range) | 0.5 (1-9) | ||
| Lymph node ratio (range) | 0.068 (0-1) | ||
| LVSI n (%) | Absent | 83 (82) | |
| Present | 19 (18) | ||
| Deep stromal invasion n (%) | Absent | 66 (65) | |
| Present | 36 (35) | ||
| Parametrium infiltration n (%) | Absent | 78 (77) | |
| Present | 24 (23) | ||
| Surgical-margin status n (%) | Negative | 89 (88) | |
| Positive | 13 (12) | ||
| Postoperative radiotherapy n (%) | Yes | 57 (56) | |
| No | 45 (44) | ||